I said YTD. It’s an individual stock in a tiny biotech, it fluctuates. Most of the market volatility has come YTD overall for the broader markets. It is very impressive that since rates started rapidly rising, it has fluctuated around a very stable, relatively flat price, sometimes above and sometimes slightly below, but quite stable. That speaks to the confidence of the investors that wait for actual publication of TLD and expected regulatory approval ahead.
5 years, also still substantially larger gains here than typical other stocks in this sector.
I can post the charts all day long to prove it.
As for the false notion that they “manipulated trial data”, I have explained why that is a lie so many times it’s not worth another run. Completely false. You’d have to presume a worldwide conspiracy so ridiculous it’s laughable.
Market Data 
Markets 
AI
